🇮🇱 Country Profile

Israel

Medicine from India reaching Israel

🇮🇱 $58.0M
All data from DGCIS India export records (fiscal year, April–March).
$58.0M
Scale
Israel's healthcare system receives $58.0M in Indian pharmaceutical products each year — affordable, quality medicine.
56%
Medicine
Primarily medicine ingredients (56%), supplemented by medicines and surgical & hospital supplies.
Context
Part of India's pharmaceutical supply network across Middle East.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Israel — building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharma categories from DGCIS (487-code basket)

Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $32.6M (55.8%) Medicines $16.4M (28.1%) Surgical & Hospital Supplies $5.8M (10.0%) Vaccines $2.6M (4.5%) Traditional & Herbal $0.97M (1.7%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in Israel Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Israel: $7.0M across 6 filings (2011-2018).